Holen Sie sich die Stockscreener-App
4.11
2.49%
0.10
Handel nachbörslich:
4.15
0.04
+0.97%
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Published on: 2025-08-15 06:30:05 - newsyoung.net
Aquestive Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts - simplywall.st
Aquestive Therapeutics Announces $75M Strategic Funding - citybiz
Aquestive’s $85M offering and royalty deal; Basilea gets rights to UTI drug candidate - Endpoints News
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Aquestive Therapeutics stock rises after securing $75 million funding deal By Investing.com - Investing.com Australia
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail - Stocktwits
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Have Been Cutting Their Estimates - 富途牛牛
Aquestive Therapeutics Prices $85 Million Common Stock Offering - MarketScreener
Aquestive Therapeutics rises after pricing $85M stock offering - MSN
Aquestive Therapeutics prices $85 million public offering By Investing.com - Investing.com Canada
Aquestive Therapeutics Secures $75 Million Funding Agreement with RTW - MarketScreener
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock - GlobeNewswire
Aquestive Secures $85M Backing to Launch Novel Sublingual Film for Severe Allergic Reactions - Stock Titan
First-Ever Oral Emergency Allergy Treatment Gets $75M Boost from RTW Investment - Stock Titan
Aquestive Therapeutics Inc. Forms Bullish Flag — Upside AheadTrend Reversal & Scalable Portfolio Growth Ideas - 선데이타임즈
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript - Insider Monkey
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
Aquestive Therapeutics Inc. Rebound Backed by Sentiment ShiftJuly 2025 Intraday Action & High Accuracy Swing Trade Signals - 선데이타임즈
Aquestive Therapeutics Reports Q2 2025 Financial Results - TipRanks
Aquestive Therapeutics, Inc. announced that it expects to receive $75 million in funding - MarketScreener
Aquestive Therapeutics Q2 2025 Earnings: What to Expect - AInvest
Aquestive's Q2 2025 Earnings Call: Navigating Contradictions in FDA Approval, Launch Readiness, and Market Strategy - AInvest
Aquestive Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AQST) - Seeking Alpha
Transcript : Aquestive Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Earnings call transcript: Aquestive Therapeutics Q2 2025 sees EPS beat, revenue miss - Investing.com UK
Aquestive Therapeutics Q2 2023 Earnings Report & AnalysisNews and Statistics - IndexBox
Aquestive 2025 Q2 Earnings Net Loss Widens Sharply - AInvest
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates - MSN
Aquestive Therapeutics: Q2 Earnings Snapshot - Stamford Advocate
Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Aquestive Therapeutics shares rise 2.33% after-hours after FDA accepts NDA submission for Anaphylm™. - AInvest
Aquestive Therapeutics: Positioning for a Game-Changing 2026 Launch of Anaphylm - AInvest
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues By Investing.com - Investing.com South Africa
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues - Investing.com
Aquestive Therapeutics earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Aquestive Therapeutics Inc (AQST) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Aquestive Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Aquestive Therapeutics Inc Q2 2025 Earnings Preview: Revenue Expectations Fall to $11.32M, Earnings at -$0.17 per Share - AInvest
Aquestive Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Uncovering Potential: Aquestive Therapeutics's Earnings Preview - 富途牛牛
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
What caused AQST's surprising Q2 2024 EPS surge? - AInvest
Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET - The Manila Times
Aquestive Therapeutics Q2 2025 Earnings Release Date Set for August 11 | AQST Stock News - Stock Titan
Why is Aquestive Therapeutics Inc. stock attracting strong analyst attentionInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Aquestive Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News
What makes Aquestive Therapeutics Inc. stock price move sharplyAccelerated investment success - Jammu Links News
How does Aquestive Therapeutics Inc. compare to its industry peersCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Aquestive Therapeutics Inc. stockDiscover breakthrough investment opportunities - Jammu Links News
What drives Aquestive Therapeutics Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Aquestive Therapeutics Inc. stockInvest confidently with data-driven strategies - Jammu Links News
What analysts say about Aquestive Therapeutics Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How strong is Aquestive Therapeutics Inc. company’s balance sheetExceptional market performance - Jammu Links News
What are the latest earnings results for Aquestive Therapeutics Inc.Unlock powerful stock screening tools today - Jammu Links News
What are Aquestive Therapeutics Inc. company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
1.29%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):